Answers are grounded in this paper and cite their sources.
This review emphasizes the need for careful, evidence-based pharmacological management in elderly cardiovascular patients, balancing life-prolonging benefits against the risks of polypharmacy and age-related physiological changes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
R. H. C. Schwinger (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: